4//SEC Filing
ALDER BIOPHARMACEUTICALS INC 4
Accession 0001209191-17-010156
CIK 0001423824operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:10 PM ET
Size
9.3 KB
Accession
0001209191-17-010156
Insider Transaction Report
Form 4
Schatzman Randall C
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2017-02-09$1.65/sh+30,000$49,500→ 145,172 total - Sale
Common Stock
2017-02-09$25.03/sh−30,000$750,756→ 115,172 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-02-09−30,000→ 78,181 totalExercise: $1.65Exp: 2018-07-22→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2016.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2016.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
- [F4]The shares subject to this stock option are fully vested.
Documents
Issuer
ALDER BIOPHARMACEUTICALS INC
CIK 0001423824
Entity typeoperating
Related Parties
1- filerCIK 0001423824
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:10 PM ET
- Size
- 9.3 KB